Yarrow Bioscience Inc

YARW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016
Assets
Cash & Equivalents $10.2M $4.0M
Accounts Receivable $786.0K $0
Inventory — —
Total Current Assets $63.9M $31.5M
Property, Plant & Equipment $28.0K $27.0K
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $66.9M $42.1M
Liabilities
Accounts Payable $2.5M $1.5M
Total Current Liabilities $7.8M $3.9M
Long-Term Debt — —
Total Liabilities $14.6M $12.5M
Stockholders' Equity
Retained Earnings $-59.2M $-30.1M
Total Stockholders' Equity $68.6M $-29.4M
← Newer Page 2 of 2 Older →